2 April 2014
Last updated at 19:49 ET
Ketamine offers an avenue of research into a field that has struggled to find new treatments for depression
Some patients who have faced incurable depression for decades
have had symptoms disappear within hours of taking low doses of the
drug.
The small trial on 28 people, reported in the Journal of Psychopharmacology, shows the benefits can last months.
Experts said the findings opened up a whole new avenue of research.
Depression is common and affects one-in-10 people at some point in their lives.
A team at Oxford Health NHS Foundation Trust gave patients doses of ketamine over 40 minutes on up to six occasions.
Eight showed improvements in reported levels of depression, with four of them improving so much they were no longer classed as depressed.
Some responded within six hours of the first infusion of ketamine.
Lead researcher Dr Rupert McShane said: "It really is dramatic for some people, it's the sort of thing really that makes it worth doing psychiatry, it's a really wonderful thing to see.
He added: "[The patients] say 'ah this is how I used to think' and the relatives say 'we've got x back'."
Dr McShane said this included patients who had lived with depression for 20 years.
The duration of the effect is still a problem.
Some relapse within days, while others have found they benefit for around three months and have since had additional doses of ketamine.
There are also some serious side-effects including one case of the supply of blood to the brain being interrupted.
"It is exciting, but it's not about to be a routine treatment as where we need to be going is maintaining the response... it's not about to replace prozac."
However, it does offer a new avenue of research into a field that has struggled to find new treatments for depression.
'Something chemical'
Ketamine 'exciting' depression therapy
Ketamine offers an avenue of research into a field that has struggled to find new treatments for depression
The
illegal party drug ketamine is an "exciting" and "dramatic" new
treatment for depression, say doctors who have conducted the first trial
in the UK.
The small trial on 28 people, reported in the Journal of Psychopharmacology, shows the benefits can last months.
Experts said the findings opened up a whole new avenue of research.
Depression is common and affects one-in-10 people at some point in their lives.
Continue reading the main story
Lead researcher Dr Rupert McShane"It really is dramatic for some people, it's the sort of thing really that makes it worth doing psychiatry”
Antidepressants, such as prozac,
and behavio
ural therapies help some patients, but a significant
proportion remain resistant to any form of treatment.
Eight showed improvements in reported levels of depression, with four of them improving so much they were no longer classed as depressed.
Some responded within six hours of the first infusion of ketamine.
Lead researcher Dr Rupert McShane said: "It really is dramatic for some people, it's the sort of thing really that makes it worth doing psychiatry, it's a really wonderful thing to see.
He added: "[The patients] say 'ah this is how I used to think' and the relatives say 'we've got x back'."
Dr McShane said this included patients who had lived with depression for 20 years.
The testing of ketamine has indentified some serious side-effects
Some relapse within days, while others have found they benefit for around three months and have since had additional doses of ketamine.
There are also some serious side-effects including one case of the supply of blood to the brain being interrupted.
"It is exciting, but it's not about to be a routine treatment as where we need to be going is maintaining the response... it's not about to replace prozac."
However, it does offer a new avenue of research into a field that has struggled to find new treatments for depression.
'Something chemical'
David Taylor, professor of psychopharmacology at King's
College London, told the BBC: "In these kinds of patients, spontaneous
remission almost never happens, people going to these clinics are at the
end of the road.
"It shows that depression is something chemical, that it can be reversed with chemicals, it dispenses for once and for all that you can just pull your socks up.
"What restricts it is the potential for disturbing psychological adverse effects and the route by which is given - intravenous - does restrict it to a small number of people."
He said in the future drug companies would develop a chemical that had the benefits, but without the side-effects, and that could be taken by something such as an inhaler.
The Home Office is reclassifying ketamine in the UK to be a class B drug, although it is already used in medicine for the treatment of back pain and as an anaesthetic.
"It shows that depression is something chemical, that it can be reversed with chemicals, it dispenses for once and for all that you can just pull your socks up.
"What restricts it is the potential for disturbing psychological adverse effects and the route by which is given - intravenous - does restrict it to a small number of people."
He said in the future drug companies would develop a chemical that had the benefits, but without the side-effects, and that could be taken by something such as an inhaler.
The Home Office is reclassifying ketamine in the UK to be a class B drug, although it is already used in medicine for the treatment of back pain and as an anaesthetic.
No comments:
Post a Comment
Please leave a comment-- or suggestions, particularly of topics and places you'd like to see covered